You just read:

Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases Up To Approximately $25.0 Million of Non-Convertible Preferred Stock and Warrants and Additional Investment Right Exercisable at Market Price

News provided by

Cell Therapeutics, Inc.

Feb 18, 2011, 01:30 ET